Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Analysts have reset their Nufarm price targets into a higher A$3.50 to A$3.60 range, compared with an unchanged fair value estimate of A$3.48. The move is tied closely to views on a cyclical inflection in Crop Protection and Seeds, alongside management's push on margins, costs, capex and cashflow. As you read on, you will see how this evolving story is shaping the way analysts frame risks, opportunities and what to watch next.
Wall Street's queuing for one rocket.While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page .
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
Jefferies lifted its Nufarm rating and moved its price target to A$3.50 from A$2.66, pointing to a confirmed cyclical inflection in Crop Protection and Seeds and a clearer path to deleveraging through an improved cashflow outlook.
-
RBC Capital raised its price target to A$3.60 from A$3.40 and highlights management's focus on margins over volumes, a cost reduction program and a lower capex outlook as key supports for potential returns under normal seasonal and market conditions.
-
Together, the Jefferies and RBC Capital reports frame Nufarm as a story where execution on cost, capital allocation and cash generation could be as important as top line trends when assessing valuation.
🐻 Bearish Takeaways
-
Both Jefferies and RBC Capital reference conditions such as cyclical inflection and normal seasonal and market settings, which signals that Nufarm's progress still depends on factors outside management's direct control.
-
The focus on deleveraging and capital efficiency implies that balance sheet and cashflow outcomes remain key watchpoints if the expected operational benefits are slower to arrive.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
See how Nufarm's fair value stacks up across multiple valuation models — not just analyst targets.
How This Changes the Fair Value For Nufarm
-
Fair value stays at A$3.48, matching the prior A$3.48 assessment.
-
Revenue growth assumption is broadly steady at 6.03%, compared with 6.03% previously.
-
Net profit margin assumption is now 4.64%, compared with 4.59% previously.
-
Assumed future P/E multiple is now 9.46x, compared with 9.56x previously.
-
The discount rate is now 9.15%, compared with 9.14% previously.
Never Miss an Update: Follow The Narrative
Narratives connect a company's business story, its industry context, and analyst assumptions to a financial forecast and fair value. They update as new data, risks, and milestones come through, so you can see how the story is evolving in real time.
Head over to the Simply Wall St Community and follow the Narrative on Nufarm to stay up to date on:
-
How expansion in biologicals, specialty crops, and platforms like Carinata and plant based omega 3 is linked to demand for more sustainable, higher margin agricultural solutions.
-
Progress on global growth, including South America, and on supply chain and cost saving initiatives that are aimed at improving earnings quality and cash generation.
-
Key risks such as high financial leverage, funding needs for Seed Technologies, volatile omega 3 markets, trade policy uncertainty, and weather driven swings in crop protection demand.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NUF.AX .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
